This leads to a lower number of growing follicles when compared with the standard long GnRH agonist protocol, which is why GnRH antagonist protocols are the first-choice treatment in women with high ovarian reserves at risk of OHSS. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.